| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on June 11, 2005
From the Department of Medicine (V.R.B., L.D., S.F., M.F.L.), Pediatrics (J.R., S.K.D.), Molecular Physiology & Biophysics (J.D.M.), Nephrology (M.D.B.), Pathology (S.F.), and Pharmacology (M.F.L.) of Vanderbilt University Medical Center, Nashville, Tenn. * To whom correspondence should be addressed. E-mail: vladimir.babaev{at}vanderbilt.edu.
Background--Cyclooxygenase-1 (COX-1) has been implicated in the pathogenesis of atherothrombosis and is expressed by the major cell types of atherosclerotic lesions. COX-1-mediated platelet thromboxane (TX) production has been proposed to promote both early atherosclerosis and thrombosis. Here, we examined the impact of COX-1 deficiency in bone marrow-derived cells on early atherogenesis in the mouse. Methods and Results--LDL receptor (LDLR)-/- and apolipoprotein E (apoE)-/- recipient mice were lethally irradiated and transplanted with COX-1-/- bone marrow. Mice reconstituted with COX-1-/- marrow had nearly complete (99.7%) loss of platelet TXA2 and significantly suppressed levels of macrophage and urinary TXA2 metabolites. Serum lipid levels and lipoprotein distributions did not differ between recipients reconstituted with COX-1+/+ and COX-1-/- marrow. Surprisingly, the extent of atherosclerotic lesions in both LDLR-/- and apoE-/- mice reconstituted with COX-1-/- marrow was increased significantly compared with control mice transplanted with COX-1+/+ marrow. Peritoneal macrophages isolated from LDLR-/- mice reconstituted with COX-1-/- marrow had increased lipopolysaccharide-induced levels of COX-2 mRNA and protein expression. Fetal liver cell transplantation studies revealed a 30% increase in atherosclerosis in COX-1-/- Conclusions--COX-1 deficiency in bone marrow-derived cells worsens early atherosclerosis in apoE-/- and LDLR-/- mice despite virtual elimination of platelet TX production. These data demonstrate that platelet TX production does not aggravate early atherosclerotic lesion formation and that upregulation of COX-2 expression in COX-1-/- macrophages is proatherogenic.
Revised on September 28, 2005
Accepted on October 21, 2005
Cyclooxygenase-1 Deficiency in Bone Marrow Cells Increases Early Atherosclerosis in Apolipoprotein E- and Low-Density Lipoprotein Receptor-Null Mice
Vladimir R. Babaev PhD*,
LDLR-/-mice compared with COX-1+/+
LDLR-/-mice, whereas the extent of atherosclerosis was unchanged in COX-1-/-/COX-2-/-
LDLR-/-mice.
This article has been cited by other articles:
![]() |
T. Cyrus, Y. Yao, T. Ding, J. M. Dogne, and D. Pratico Thromboxane receptor blockade improves the antiatherogenic effect of thromboxane A2 suppression in LDLR KO mice Blood, April 15, 2007; 109(8): 3291 - 3296. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |